{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-26-004944","form_type":"8-K","ticker":"TLRY","cik":"0001731348","company_name":"Tilray Brands, Inc.","filed_at":"2026-07-28T20:05:18+00:00","discovered_at":"2026-07-28T20:06:00.479064+00:00","generated_at":"2026-07-28T20:06:29.924665+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Tilray Brands reports record FY2026 revenue of $915.5M, adjusted EBITDA $61.1M, guides FY2027 EBITDA $68-75M","bullets":["FY2026 net revenue $915.5M (+11% YoY); adjusted EBITDA $61.1M; net loss $105.2M ($1.09 loss per share).","Q4 net revenue $281.7M (+25% YoY); adjusted EBITDA $31.9M; adjusted EPS $0.05.","FY2027 guidance: adjusted EBITDA $68M-$75M, double-digit growth.","International medical cannabis revenue up 34% in FY2026; cash & securities ~$235M; net debt $0.7M.","BrewDog acquisition expanded beverage platform; U.S. rescheduling evaluation ongoing."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-26-004944","json":"https://secwatch.observer/filing/0001171843-26-004944.json","markdown":"https://secwatch.observer/filing/0001171843-26-004944.md","text":"https://secwatch.observer/filing/0001171843-26-004944.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1731348/000117184326004944/0001171843-26-004944-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1731348/000117184326004944/f8k_072826.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-28T20:06:29.924665+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}